Sorrento Therapeutics (SRNE) Reports Q3 Loss of $0.03/Share
Tweet
Share
E-mailGet Alerts SRNE Hot Sheet
Join SI Premium – FREE
Sorrento Therapeutics (NASDAQ: SRNE) reported Q3 EPS of ($0.03), versus ($0.27) reported last year. Revenue for the quarter came in at $1.1 million, versus $1.28 million reported last year.
For earnings history and earnings-related data on Sorrento Therapeutics (SRNE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- zSpace, Inc. (ZSPC) Reports Q2 results
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
